Portland, OR, Nov. 18, 2022 (GLOBE NEWSWIRE) -- A new business intelligence report released by Allied Market Research, the global Pediatric Vaccines Market was estimated at $21.4 billion in 2021 and is expected to hit $36.4 billion by 2031, registering a CAGR of 5.4% from 2022 to 2031. The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and evolving market trends. The market study is a helpful source of information for the frontrunners, new entrants, investors, and shareholders in crafting strategies for the future and heightening their position in the market.
Download Free Sample Report: https://www.alliedmarketresearch.com/request-sample/438
Report coverage & details:
| Report Coverage | Details |
| Forecast Period | 2022–2031 |
| Base Year | 2021 |
| Market Size in 2021 | $21.4 Billion |
| Market Size in 2031 | $36.4 Billion |
| CAGR | 5.4% |
| No. of Pages in Report | 310 |
| Segments Covered | Technology, Type, Indication, and Region. |
| Drivers | Rising awareness regarding the benefits of vaccination in prevention of diseases |
| Restraints | Increasing cost of vaccines and low accessibility in remote areas |
| Opportunities | Surge in demand from the emerging markets |
Covid-19 scenario-
- The outbreak of the pandemic impacted the supply chain, giving way to lower demand and higher inventory adjustments. This factor impacted the global pediatric vaccines market negatively.
- However, the market has now got back on track.
The global pediatric vaccines market is analyzed across technology, type, indication, and region. The report takes in an exhaustive analysis of segments and their sub-segments with the help of tabular and graphical representation. Investors and market players can benefit from the breakdown and devise stratagems based on the highest revenue-generating and fastest-growing segments stated in the report.
Based on technology, the subunit, recombinant, polysaccharide, and conjugate vaccines segment contributed to more than two-fifths of the global pediatric vaccines market revenue in 2021, and is expected to dominate by 2031. The same segment would also showcase the fastest CAGR of 6.3% throughout the forecast period.
Purchase Inquiry: https://www.alliedmarketresearch.com/purchase-enquiry/438
Based on type, the monovalent segment accounted for around four-fifths of the total market revenue in 2021, and is expected to dominate by 2031. The multivalent segment, simultaneously, would cite the fastest CAGR of 6.9% throughout the forecast period.
Based on indication, the pneumoccocal disease segment held nearly one-fifth of the total market revenue in 2021, and is expected to dominate by 2031. The human papilloma virus segment, however, would cite the fastest CAGR of 7.8% throughout the forecast period.
Based on region, the market across North America generated more than two-fifths of the total market revenue in 2021, and is anticipated to retain the lion’s share by 2031. The Asia-Pacific region, at the same time, would showcase the fastest CAGR of 6.9% during the forecast period. The other regions studied in the report include LAMEA and Europe.
The key market players analyzed in the global pediatric vaccines market report include Pfizer, Johnson & Johnson, AstraZeneca plc., GlaxoSmithKline plc., Sanofi Aventis, Novavax, Inc., Merck & Co., Inc., Serum Institute of India Pvt. Ltd., Emergent BioSolutions Inc., and CSL Limited. These market players have embraced several strategies including partnership, expansion, collaboration, joint ventures, and others to highlight their prowess in the industry. The report is helpful in formulating the business performance, product portfolio, operating segments, and developments by the top players.
Trending Reports in Healthcare Industry (Book Now with 10% Discount):
mHealth Market by Type (mHealth Devices and mHealth Services), Stakeholders (Mobile Operators, Device Vendors, Healthcare Providers, and Content Players), and Application (Cardiovascular Diseases, Diabetes, Respiratory diseases, Neurological Disorders, and Others): Global Opportunity Analysis and Industry Forecast, 2020-2030
Oncology-Cancer Drugs Market By Drug Class Type (Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), and Hormonal Therapy), By Indication (Lung Cancer, Stomach Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, Liver Cancer, Esophagus Cancer, Cervical Cancer, Kidney Cancer, Bladder Cancer, and Other Cancers): Opportunity Analysis and Industry Forecast, 2021-2030
Tattoo Removal Market by Procedure (Laser Procedure, Surgical Procedure, Creams, and Other Procedures) and End User (Hospitals, Clinics, and Others): Global Opportunity Analysis and Industry Forecast, 2020-2030
AI in Healthcare Market by Offering (Software, Hardware, & Services), Algorithm (Deep Learning, Querying Method, Natural Language Processing, and Context Aware Processing), Application (Robot-Assisted Surgery, Virtual Nursing Assistant, Administrative Workflow Assistance, Fraud Detection, Dosage Error Reduction, Clinical Trial Participant Identifier, Preliminary Diagnosis, and Others), and End User (Healthcare Providers, Pharmaceutical & Biotechnology Companies, Patients, and Payer): Global Opportunity Analysis and Industry Forecast, 2021-2030
Point of Care Diagnostics Market by Product (Glucose Monitoring Kits, Infectious Diseases Testing Kits, Pregnancy And Fertility Testing Kits, Hematology Testing Kits, Cardiometabolic Monitoring Kits, Urinalysis Testing Kits, Cholesterol Test Strips, Drugs Abuse Testing Kits, Others), by Mode Of Prescription (Prescription Based Devices, Otc Based Devices), by End User (Professional Diagnostic Centers, Research Laboratories, Home Care, Others): Global Opportunity Analysis and Industry Forecast, 2020-2030
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
